Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Current Assets    
Cash and cash equivalents $ 27,621 $ 28,296
Accounts receivable (net of allowances of $1,383 and $1,285, respectively) 72,112 69,590
Inventories 228,074 212,930
Prepaid expenses and other current assets 10,356 7,585
Total current assets 338,163 318,401
Property, Plant and Equipment, net 57,087 58,503
Other Assets    
Operating lease right-of-use assets 23,365 26,444
Goodwill 237,238 242,661
Other intangible assets, net 253,484 266,939
Deferred tax assets, net 2,006 1,993
Other assets 9,335 7,638
Total Assets 920,678 922,579
Current Liabilities    
Accounts payable 57,624 55,182
Accrued expenses and other current liabilities 24,498 30,733
Contingent consideration payable 0 54,113
Current portion of operating lease liabilities 8,308 7,950
Current portion of long-term debt 3,750 3,750
Total current liabilities 94,180 151,728
Non-Current Liabilities    
Long-term debt 432,314 383,484
Warrant liabilities 394 2,053
Deferred tax liabilities, net 32,190 35,090
Operating lease liabilities, less current portion 18,652 22,575
Other liabilities 13,604 13,778
Total Liabilities 591,334 608,708
Commitments and Contingencies (Note 8) 0 0
Stockholders’ Equity    
Preferred shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding at June 30, 2022 and December 31, 2021 0 0
Common stock, $0.0001 par value; 220,000,000 shares authorized; 41,973,680 and 38,871,646 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively 4 4
Additional paid-in capital 359,095 330,616
Accumulated deficit (22,384) (26,436)
Accumulated other comprehensive income (loss) (7,371) 9,687
Total stockholders’ equity 329,344 313,871
Total Liabilities and Stockholders’ Equity $ 920,678 $ 922,579